Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

Background: Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection is associated with hypercoagulability caused by direct invasion of endothelial cells and/or proinflammatory cytokine release. Thromboprophylaxis with enoxaparin is recommended by current guidelines, but evidence is st...

Full description

Bibliographic Details
Main Authors: Filippo Albani, Lilia Sepe, Federica Fusina, Chiara Prezioso, Manuela Baronio, Federica Caminiti, Antonella Di Maio, Barbara Faggian, Maria Elena Franceschetti, Marco Massari, Marcello Salvaggio, Giuseppe Natalini
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:EClinicalMedicine
Subjects:
Coronavirus
SARS-CoV-2
COVID-19
Heparin
Low molecular weight heparin
Thromboprophylaxis
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020303060

Similar Items

Similar Items